Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 Genes and the Therapeutic Warfarin Dose in Brazilian Patients with Thrombosis: A Prospective Cohort Study

被引：0
|
作者：
Vanessa Cristina de Oliveira Almeida
Daniel Dias Ribeiro
Karina Braga Gomes
Ana Lúcia Brunialti Godard
机构：
[1] Instituto de Ciências Biológicas,Department of General Biology
[2] Universidade Federal de Minas Gerais,Department of Molecular Genetics
[3] Hermes Pardini,Clinical Hospital
[4] Universidade Federal de Minas Gerais,Department of Clinical and Toxicological Analysis, Faculty of Pharmacy
[5] Universidade Federal de Minas Gerais,undefined
来源：
Molecular Diagnosis & Therapy | 2014年 / 18卷
关键词：
Warfarin; International Normalize Ratio; Warfarin Dose; Brazilian Population; UGT1A1 Gene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：675 / 683
页数：8
相关论文
共 50 条
  • [41] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [42] VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis
    Pasmant, Eric
    de Beauvoir, Charlotte
    Plessier, Aurelie
    Labreuche, Julien
    Bezeaud, Annie
    THROMBOSIS RESEARCH, 2010, 126 (02) : E134 - E136
  • [43] Polymorphism of the CYP2C9 and VKORC1 genes: a comment
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JORNAL VASCULAR BRASILEIRO, 2021, 20
  • [44] Role of CYP2C9 and VKORC1 Polymorphisms in Patients With Hypersensitivity to Acenocoumarol
    Outeda-Macias, M.
    Salvador-Garrido, P.
    Martinez-Lopez, L. M.
    Sanchez-Parada, L.
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 712 - 712
  • [45] Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
    Flockhart, David A.
    O'Kane, Dennis
    Williams, Marc S.
    Watson, Michael S.
    Flockhart, David A.
    Gage, Brian
    Gandolfi, Roy
    King, Richard
    Lyon, Elaine
    Nussbaum, Robert
    O'Kane, Dennis
    Schulman, Kevin
    Veenstra, David
    Williams, Marc S.
    Watson, Michael S.
    GENETICS IN MEDICINE, 2008, 10 (02) : 139 - 150
  • [46] Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals
    Alrashid, Maryam H.
    Al-Serri, Ahmad
    Alshemmari, Salem H.
    Koshi, Philip
    Al-Bustan, Suzanne A.
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (02) : 183 - 190
  • [47] Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals
    Maryam H. Alrashid
    Ahmad Al-Serri
    Salem H. Alshemmari
    Philip Koshi
    Suzanne A. Al-Bustan
    Molecular Diagnosis & Therapy, 2016, 20 : 183 - 190
  • [48] Influence of CYP2C9 and VKORC1 Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People
    Esmerian, Maria O.
    Mitri, Zahi
    Habbal, Mohammad-Zuheir
    Geryess, Eddy
    Zaatari, Ghazi
    Alam, Samir
    Skouri, Hadi N.
    Mahfouz, Rami A.
    Taher, Ali
    Zgheib, Nathalie K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (10): : 1418 - 1428
  • [49] Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
    Haug K.B.F.
    Sharikabad M.N.
    Kringen M.K.
    Narum S.
    Sjaatil S.T.
    Johansen P.W.
    Kierulf P.
    Seljeflot I.
    Arnesen H.
    Brørs O.
    Thrombosis Journal, 6 (1)
  • [50] Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients
    Sripriya Natarajan
    Chandrashekhar K. Ponde
    Rajesh M. Rajani
    Farah Jijina
    Roopkumar Gursahani
    Pradnya P. Dhairyawan
    Tester F. Ashavaid
    Pharmacological Reports, 2013, 65 : 1375 - 1382
12345